New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress.

Imlimthan, Surachet; Moon, Euy Sung; Rathke, Hendrik; Afshar-Oromieh, Ali; Rösch, Frank; Rominger, Axel; Gourni, Eleni

Imlimthan, Surachet; Moon, Euy Sung; Rathke, Hendrik; Afshar-Oromieh, Ali; Rösch, Frank; Rominger, Axel; Gourni, Eleni.

Afiliação

Imlimthan S; Department of Nuclear Medicine, the Inselspital, Bern University Hospital, University of Bern, CH-3010 Bern, Switzerland.
Moon ES; Department of Chemistry-TRIGA Site, Johannes Gutenberg-University Mainz, 55128 Mainz, Germany.
Rathke H; Department of Nuclear Medicine, the Inselspital, Bern University Hospital, University of Bern, CH-3010 Bern, Switzerland.
Afshar-Oromieh A; Department of Nuclear Medicine, the Inselspital, Bern University Hospital, University of Bern, CH-3010 Bern, Switzerland.
Rösch F; Department of Chemistry-TRIGA Site, Johannes Gutenberg-University Mainz, 55128 Mainz, Germany.
Rominger A; Department of Nuclear Medicine, the Inselspital, Bern University Hospital, University of Bern, CH-3010 Bern, Switzerland.
Gourni E; Department of Nuclear Medicine, the Inselspital, Bern University Hospital, University of Bern, CH-3010 Bern, Switzerland.

Pharmaceuticals (Basel) ; 14(10)2021 Oct 05.

Article em En | MEDLINE | ID: mdl-34681246

Palavras-chave

cancer-associated fibroblast; fibroblast activation protein; fibroblast activation protein inhibitor; nuclear imaging; radiotherapy; tumor microenvironment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google